Tiny particles in lung fluid may predict cancer treatment success
NCT ID NCT07262671
First seen Jan 09, 2026 · Last updated May 15, 2026 · Updated 16 times
Summary
This study aims to see if exosomes—tiny particles released by cells—found in blood and lung fluid can help predict how well treatment works in people with advanced non-small cell lung cancer that has spread to the lining of the lung. Researchers will collect samples from 100 patients before and during standard therapy (like immunotherapy or chemotherapy) and compare the exosome RNA patterns to treatment response. The goal is to find a way to personalize treatment decisions without adding new drugs or procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Cancer hospital of Fudan University
Shanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.